Page 9 - உலகளாவிய பிரசாதம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange
globalbankingandfinance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalbankingandfinance.com Daily Mail and Mail on Sunday newspapers.
Medesis Pharma Lists Successfully On Euronext Growth To Launch Several Phase II Clinical Trials Date
12/02/2021
Euronext today congratulates the biotech company Medesis Pharma from Montpellier for its listing on Euronext Growth Paris (ticker code: ALMDP).
Founded in 2003, Medesis Pharma has developed a technology that allows the oral administration of active pharmaceutical ingredients, with the aim of addressing serious diseases for which there is no effective treatment. The biotech company goes public today in order to accelerate its development thanks to new recruitments, new collaborative programmes, and the realisation of at least three phase II clinical trials in 2021.
Medesis Pharma was listed through the admission to trading of the 4,357,453 shares making up its equity, of which 1,087,773 new shares were issued under a Global Offering[1], including the full exercise of the extension clause and the exercise of the over-allotment option.
Calliditas Therapeutics launches proposed global offering
Search jobs
Calliditas Therapeutics launches proposed global offering
January 26, 2021
Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX; Nasdaq – CALT) will today launch a proposed public offering of American Depositary Shares ( ADSs ), in the United States for trading on The Nasdaq Global Select Market in the United States (the “U.S. Offering”) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the Private Placement”, and together with the U.S. Offering, the “Global Offering”). The target size of the Global Offering is 4,500,000 common shares plus a potential 30-day over-allotment option of 15 percent of the common shares (including common shares in the form of ADSs) offered by Calliditas at the U.S. Offering price. The Global Offering is subject to market conditions and investor demand and
Calliditas Therapeutics launches proposed global offering
News provided by
Share this article
Calliditas Therapeutics AB (publ) ( Calliditas ) (Nasdaq OMX: CALTX) (Nasdaq: CALT)
will today launch a proposed public offering of American Depositary Shares ( ADSs ), in the United States for trading on The Nasdaq Global Select Market in the United States (the U.S. Offering ) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the Private Placement , and together with the U.S. Offering, the Global Offering ). The target size of the Global Offering is 4,500,000 common shares plus a potential 30-day over-allotment option of 15 percent of the common shares (including common shares in the form of ADSs) offered by Calliditas at the U.S. Offering price. The Global Offering is subject to market conditions and investor demand and the number of ADSs (which represents two common shares) and common shar
(2)
PXG Expands its Global Offerings with Game-changing New Driver, Fairway Wood, Hybrid, and Iron Technologies
SCOTTSDALE, Ariz., Jan. 10, 2021 /PRNewswire/ PXG, the global golf equipment powerhouse, is all about the performance - crazy distance, unbelievable forgiveness, huge sweet-spots, an extremely soft feel, and smoking hot looks. All that and more can be found in the company s All-New PXG 2021 0211 Collection. An incredible line-up of innovative new irons, hybrids, fairways, and drivers that deliver game-changing performance at a killer price. It has always been PXG s mission to develop the world s finest golf equipment, and the PXG 2021 0211 Collection is no exception, said PXG founder and CEO Bob Parsons. 0211s are an easy choice for players who simply want a sexy set of clubs that deliver unbelievable performance at a price you wouldn t expect - certainly not from us.
vimarsana © 2020. All Rights Reserved.